Cargando…
IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming
To understand the role of polyploid giant cancer cells (PGCCs) in drug resistance and disease relapse, we examined the mRNA expression profile of PGCCs following treatment with paclitaxel in ovarian cancer cells. An acute activation of IL-6 dominated senescence-associated secretory phenotype lasted...
Autores principales: | Niu, Na, Yao, Jun, Bast, Robert C., Sood, Anil K., Liu, Jinsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481288/ https://www.ncbi.nlm.nih.gov/pubmed/34588424 http://dx.doi.org/10.1038/s41389-021-00349-4 |
Ejemplares similares
-
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells
por: Li, Xiaoran, et al.
Publicado: (2023) -
Coevolution of neoplastic epithelial cells and multilineage stroma via polyploid giant cells during immortalization and transformation of mullerian epithelial cells
por: Zhang, Shiwu, et al.
Publicado: (2016) -
Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer
por: Zhang, Xudong, et al.
Publicado: (2023) -
Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells
por: Niu, N, et al.
Publicado: (2017) -
Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts
por: Avagliano, Angelica, et al.
Publicado: (2018)